Evidence map›Paper›PMID 29378714›Full record

ArticleAntimicrobial agents and chemotherapy2018

Pharmacokinetics of Tedizolid in an Obese Patient after Bariatric Surgery.

Matthieu Grégoire, Julia Brochard Libois, Denis Waast, Benjamin Gaborit, Marc Dauty, Guillaume Deslandes, Eric Dailly, Sophie Touchais, David Boutoille, Nicolas Grégoire and 1 more

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Matthieu GrégoireClinical Pharmacology Department, CHU Nantes, Nantes, France matthieu.gregoire@chu-nantes.fr.ORCID 0000-0003-1232-5761
Julia Brochard LiboisInfectious Diseases Department, CHU Nantes and CIC 1413, INSERM, Nantes, France.
Denis WaastTrauma and Orthopedics Department, CHU Nantes, Nantes, France.
Benjamin GaboritInfectious Diseases Department, CHU Nantes and CIC 1413, INSERM, Nantes, France.
Marc DautyPhysical and Rehabilitation Medicine Department, CHU Nantes, Nantes, France.
Guillaume DeslandesClinical Pharmacology Department, CHU Nantes, Nantes, France.
Eric DaillyClinical Pharmacology Department, CHU Nantes, Nantes, France.
Sophie TouchaisTrauma and Orthopedics Department, CHU Nantes, Nantes, France.
David BoutoilleInfectious Diseases Department, CHU Nantes and CIC 1413, INSERM, Nantes, France.
Nicolas GrégoireINSERM U1070, Université de Poitiers, CHU de Poitiers, Poitiers, France.
William CouetINSERM U1070, Université de Poitiers, CHU de Poitiers, Poitiers, France.
Inserm · FRCentre d'Investigation Clinique de Nantes · FRCentre Hospitalier Universitaire de Nantes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An obese woman was treated with oral tedizolid 200 mg once daily for pseudoarthrosis 10 years after Roux-en-Y bypass surgery. Total plasma peak concentration was 2.12 mg/liter 3 h after intake, and area under the concentration-time curve from 0 to 24 h (AUC

Indexed as

Bariatric SurgeryAgedAnti-Bacterial AgentsFemaleHumansMicrobial Sensitivity TestsObesityOxazolidinonesStaphylococcusStreptococcusTetrazolesAnti-Bacterial AgentsOxazolidinonestedizolidTetrazolesbariatric surgeryobesitypharmacokineticstedizolid

Identifiers

PMID29378714
PMCPMC5913932
OpenAlexW2794374195

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.